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In recent years, ambitious global commitments have been 
made to improve programmes for the prevention of mother-
to-child transmission (PMTCT) of human immunodeficiency 
virus (HIV). In 2011, the Global Plan was launched to “elimi-
nate infant HIV infections by 2015 and keep their mothers 
alive”.1 While the target was not reached, the initiative con-
tributed to a 60% decline in infant infections from 270 000 to 
110 000 between 2009 and 2015 across 21 priority countries 
in sub-Saharan Africa.2 More recently, the Joint United Na-
tions Programme on HIV/AIDS (acquired immune deficiency 
syndrome) set targets to reach 95% of pregnant women liv-
ing with HIV with sustained, lifelong HIV treatment, and to 
reduce the annual number of newly infected children to less 
than 40 000 by the end of 2018 globally.3
Option B+ is the lifelong provision of antiretroviral 
therapy (ART) for all HIV-positive pregnant and breastfeed-
ing women regardless of immune status. The Global Plan has 
been credited with accelerating implementation of Option 
B+2,4 and improving coverage of PMTCT services for mothers 
and infants. By 2014, antenatal HIV testing exceeded 90% in 
many eastern and southern African countries.5 By the end of 
2015, more than 80% of pregnant women living with HIV in 
the 21 Global Plan countries were receiving ART for PMTCT, 
and of an estimated 1.2 million HIV-exposed infants, 51% 
(612 000) were receiving an HIV test within two months of 
birth. 6 However, despite this progress, retention of women 
in HIV care during the pregnancy and postpartum period 
continues to be challenging.7 Higher dropout rates have been 
documented after delivery and at two years of follow-up, 
suggesting that service integration and linking mothers to 
routine ART services are important determinants of retention 
in care.8–10 As well as being detrimental to their own health, 
losing mothers from care contributes to higher HIV transmis-
sion risks to their infants, and poorer uptake of services across 
the cascade of infant care.11
The timing of adoption and roll-out of PMTCT policies, 
and the extent to which policies are implemented within 
health facilities, will be important in determining whether 
countries meet global targets for mothers living with HIV and 
their infants. Furthermore, how well-prepared health systems 
are to cope with the changes is crucial to the success of these 
evolving programmes. This is particularly so in rural areas 
where most pregnant women in sub-Saharan Africa reside, and 
where policy implementation may be delayed or patchy.12 As 
policy changes lead to increasing client numbers, PMTCT pro-
grammes have faced challenges in ensuring sufficient supplies 
of HIV test kits and antiretroviral (ARV) drugs, particularly 
in rural areas.13 Stock-outs of supplies may undermine client 
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Implementing prevention policies for mother-to-child transmission 
of HIV in rural Malawi, South Africa and United Republic of Tanzania, 
2013–2016
Harriet Jones,a Alison Wringe,a Jim Todd,a John Songo,b Francesc Xavier Gómez-Olivé,c Mosa Moshabela,d 
Eveline Geubbels, Mukome Nyamhagatta,f Thoko Kalua,g Mark Urassa,h Basia Zabaa & Jenny Renjua
Objective To assess adoption of World Health Organization (WHO) guidance into national policies for prevention of mother-to-child 
transmission (PMTCT) of human immunodeficiency virus (HIV) and to monitor implementation of guidelines at facility level in rural Malawi, 
South Africa and the United Republic of Tanzania.
Methods We summarized national PMTCT policies and WHO guidance for 15 indicators across the cascades of maternal and infant care over 
2013–2016. Two survey rounds were conducted (2013–2015 and 2015–2016) in 46 health facilities serving five health and demographic 
surveillance system populations. We administered structured questionnaires to facility managers to describe service delivery. We report the 
proportions of facilities implementing each indicator and the frequency and durations of stock-outs of supplies, by site and survey round.
Findings In all countries, national policies influencing the maternal and infant PMTCT cascade of care aligned with WHO guidelines by 
2016; most inter-country policy variations concerned linkage to routine HIV care. The proportion of facilities delivering post-test counselling, 
same-day antiretroviral therapy (ART) initiation, antenatal care and ART provision in the same building, and Option B+ increased or remained 
at 100% in all sites. Progress in implementing policies on infant diagnosis and treatment varied across sites. Stock-outs of HIV test kits or 
antiretroviral drugs in the past year declined overall, but were reported by at least one facility per site in both rounds.
Conclusion Progress has been made in implementing PMTCT policy in these settings. However, persistent gaps across the infant cascade 
of care and supply-chain challenges, risk undermining infant HIV elimination goals.
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confidence and affect programme cover-
age. Increased patient numbers are not 
always offset by the recruitment of addi-
tional trained personnel, contributing to 
concerns around the quality of care.13,14
To address the programmatic chal-
lenges which are preventing countries 
from reaching global PMTCT targets, 
a better understanding is needed of 
the extent to which national policies 
align with World Health Organiza-
tion (WHO) guidance. We also need 
data about implementation gaps at the 
facility level and the consequences for 
managing supplies of drugs and diag-
nostic tests. Although previous research 
has investigated HIV policy adoption 
and implementation in sub-Saharan 
Africa,12,15–19 few studies have docu-
mented implementation of PMTCT 
policies, especially after implementation 
of Option B+, and in rural settings. This 
paper used data from policy reviews and 
health-facility surveys conducted with 
health workers between 2013 and 2016 
in five health and demographic sur-
veillance system sites in rural Malawi, 
South Africa and the United Republic of 
Tanzania. The aim was to assess whether 
the WHO guidance on PMTCT has 
been adopted in national policies and 
implemented by rural health facilities. 
As a secondary objective, we assessed 
the frequency and duration of stock-
outs of HIV test kits and drug supplies 
over the same period.
Methods
Study settings
We purposively selected three out of six 
countries participating in a wider mor-
tality study being conducted in health 
and demographic surveillance system 
sites by the network for Analysing Lon-
gitudinal Population HIV/AIDS data in 
Africa.20,21 These countries were chosen 
to represent a range of adoption dates of 
Option B+ (Malawi: 2011; South Africa: 
2015; United Republic of Tanzania: 
2013) and mother-to-child transmission 
rates (8.9% in Malawi; 5.3% in South 
Africa; 12.2% in the United Republic of 
Tanzania).22–24 The five sites are served 
by 46 health facilities providing HIV 
services to approximately 400 000 resi-
dents21 (Table 1).
HIV policy review
In 2013, we conducted a review of 
WHO guidance and national HIV poli-
cies from 2003 to 2013, covering HIV 
testing, PMTCT and ART provision.25 
In 2016, we updated the review for the 
period 2013 to 2015. The first phase 
involved a review of the literature and 
consultation with 28 HIV researchers 
and practitioners to define a concep-
tual framework with five main areas of 
health-service factors relating to deliv-
ery of HIV testing, PMTCT and ART 
services (service access and coverage; 
quality of care; coordination of care and 
patient tracking; support to people living 
with HIV; and medical management).25 
We devised 54 associated policy indica-
tors and included all 15 that pertained 
to PMTCT in this study.
The second phase involved review-
ing WHO guidelines and national policy 
documents. We retrieved these through 
online searches of websites of health 
ministries and national HIV organiza-
tion or through email communications 
or in-person visits with representatives 
of organizations. Documents were in-
Table 1. Characteristics of the five study sites included the study of the prevention of mother-to-child transmission of HIV in rural 
Malawi, South Africa and United Republic of Tanzania, 2013−2016
Variable Malawi South Africa United Republic of Tanzania
Karonga Agincourt uMkhanyakude Ifakara Kisesa
Size of site, km2 135 420 438 2 400 150
Population of site 39 045 90 000 90 000 169 000 30 486
No. (%) of HIV positive 
residentsa,b
1 943/32 983 (5.9) 775/2 670 (29.0) 2 719/8 365 (32.5) 112/2 435 (4.6) 381/5 754 (6.6)
Total no. of health facilitiesc 7 11 27 19 11
Health facility survey
No. of facilities in analysisd 5 6 17 11 7
Survey dates 
    Round 1 12 – 18 Dec 2013 21 Aug –  
27 Nov 2013
13 – 21 Jan 2015 22 Oct 2013 –  
3 Jun 2014
4 Oct 2013 –  
22 Jan 2014
    Round 2 26 – 29 May 2015 16 Jul –  
25 Nov 2015
20 May –  
3 Jun 2016
22 Sep –  
8 Oct 2015
22 Jul –  
4 Aug 2015
Service use
No. of HIV tests provided at 
antenatal care visits
    Round 1 302 231 1 940 1 551 694
    Round 2 375 422 1 196 1 891 1 034
No. of visits for PMTCT 
services
    Round 1 10 31 94 21 108
    Round 2 31 46 1 079 1 115 1 318
HIV: human immunodeficiency virus; PMTCT: prevention of mother-to-child transmission.
a  All estimates are for adults aged 15–45 years old except Kisesa, where estimates are for adults 15–49 years old.
b  Data from 2007–2012 Karonga; 2010–2011 Agincourt; 2014–2015 Ifakara; 2015 uMkhanyakude; 2016 Kisesa. 
c  Serving the population at each site.
d  Facilities offering antenatal care and PMTCT services that were surveyed in both rounds 1 and 2.
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cluded if they were nationally relevant; 
contained programmatic or clinical 
guidance on PMTCT services; and 
were published between January 2003 
and June 2015. Information from the 
documents was summarized in an Excel 
spreadsheet (Microsoft Corp. Redmond, 
United States of America) that tracked 
policy content, source, year of adoption 
and policy changes over time.
Health-facility surveys
We conducted surveys of health facili-
ties between August 2013 and January 
2015 (round 1), and between May 2015 
and June 2016 (round 2; Table 1). The 
questionnaire was informed by the 
WHO service availability and readi-
ness assessment tool,26 and covered the 
delivery of HIV testing, PMTCT and 
ART services, as described previously.17 
We conducted survey questionnaires 
face-to-face, in English, with the staff 
in charge at each facility. Interviewers 
observed the availability of treatment 
guidelines and consulted pharmacy 
records for drug stocks and availability 
of test kits.
All health facilities providing HIV 
services to the health and demographic 
surveillance system populations were 
surveyed, except one small private 
clinic in Karonga, one public facility in 
Agincourt and facilities serving fewer 
than 100 patients per month in Ifakara. 
In uMkhanyakude and Kisesa, we also 
included facilities outside the site area, 
but used by health and demographic 
surveillance system residents.17 For this 
analysis, we only included facilities that 
participated in both survey rounds and 
offered PMTCT services.
We conducted all analysis in Stata, 
version 15 (Stata Corp., College Station, 
USA). We recoded categorical variables 
as binary variables to demonstrate 
the proportion of facilities that were 
fully compliant with each policy (versus 
partial or non-compliance). We then 
used descriptive statistics to show the 
proportion of facilities implementing 
each policy, by survey round and site. 
HIV test kit and drug stock-outs were 
recorded for the previous year with 
median durations for the longest stock-
out during this period recorded in days.
Ethical approval was obtained lo-
cally for each site and from the London 
School of Hygiene and Tropical Medi-
cine (no. 8891–1). Survey participants 
provided written informed consent.
Results
Policy review
We reviewed 10 WHO guidelines and 
47 national policy documents (Box 1). 
By 2016, national policies influencing 
the maternal and infant cascades of 
care were in line with WHO guidelines 
in all three countries, despite substan-
tial variation in the years of adoption 
(Tables 2 and Table 3).
Guidance stipulating that pre- and 
post-test counselling should be provided 
was first released by WHO in 2003, and 
then adopted by Malawi in 2006, by the 
United Republic of Tanzania in 2005 
and by South Africa in 2010. Policies on 
provider-initiated testing and counsel-
ling in antenatal care were first adopted 
by Malawi in 2006, two years before 
it was recommended by WHO, and 
adopted by the United Republic of Tan-
zania in 2007 and South Africa in 2010. 
Malawi also adopted same-day ART 
initiation and Option B+ policies before 
WHO first issued its guidance. WHO 
recommendations from 2006 relating 
to linkage of mothers to routine ART 
care specify the need for clear guidance 
on when HIV-positive pregnant women 
should be referred from antenatal care 
to ART clinics, without indicating when 
it should occur. We noted variation in 
the timing of referral of pregnant or 
postpartum women to ART clinics in 
the study countries, with Malawi and 
South African policies stipulating that 
this should occur within 42 days after 
delivery. In the United Republic of 
Tanzania, the policy stipulating referral 
within 42 days was replaced in 2013 
to allow ART provision for mothers in 
reproductive health clinics until their 
child reaches 2 years old. WHO guid-
ance on infant diagnosis, prophylaxis 
and treatment were released in 2010. 
All countries aligned themselves with 
the WHO recommendations, with varia-
tions in the year of adoption.
Health facility survey
We included survey data from 46 health 
facilities serving the populations of the 
five health and demographic surveil-
lance system sites (Table 4).
Maternal care cascade
Provider-initiated testing and counsel-
ling was offered by all facilities in all sites 
for both rounds (Table 5). The greatest 
increases in the proportion of facilities 
always offering both pre- and post-test 
counselling were seen in Kisesa: from 
29% (2/7) to 86% (6/7) for pre-test 
counselling and from 57% (4/7) to 100% 
(7/7) for post-test counselling. In the 
Malawian and South African sites, all 
facilities implemented Option B+ dur-
ing round 1. Implementation of Option 
B+ was later in the United Republic of 
Tanzania, with 55% (6/11) of facilities 
in Ifakara and 71% (5/7) of facilities in 
Kisesa delivering Option B+ by round 
1, increasing to 100% in both sites by 
round 2. The proportion of facilities 
offering women ART services on the 
same day as receiving an HIV diagnosis 
at antenatal care increased or remained 
stable over the two rounds, reaching at 
least 91% by round 2 in all sites.
All five facilities in Karonga and 
87% (20/23) in the South African sites 
reported making referrals by 6 weeks 
postpartum in round 1 with little change 
in round 2. In the Tanzanian sites, 72% 
(13/18) of health facilities reported 
making maternal referrals within this 
timeframe in round 1, dropping to 6% 
(1/18) by round 2. The proportion of 
facilities reporting that health workers 
accompanied women to routine ART 
services declined by round 2 in all sites 
except Karonga. The location of ART 
provision for PMTCT also changed over 
the two rounds (Fig. 1).
Infant care cascade
Facility-level implementation of early 
infant diagnosis between 4–6 weeks by 
round 2 was high with little variation 
between sites and countries (Table 6). 
However, the provision of infant pro-
phylaxis was different between sites. In 
the South African sites, the proportion 
of facilities providing prophylaxis at 
4–6 weeks decreased from 87% (20/23) 
to 61% (14/23), with a similar decrease 
in the proportion of facilities provid-
ing prophylaxis until the cessation of 
breastfeeding, from 70% (16/23) to 61% 
(14/23). In the Malawian and Tanzanian 
sites, all facilities provided prophylaxis 
at 4–6 weeks by round 2.
The provision of infant feeding 
counselling was consistently high in 
all sites over both rounds. Infant care 
was offered in all facilities across both 
rounds in the two South African sites, 
increasing in Ifakara from 82% (9/11) to 
90% (10/11), but decreasing in Karonga 
(100%; 5/5 to 80%; 4/5) and Kisesa (57%; 
4/7 to 43%; 3/7).
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Box 1. Policy documents and guidance included in the study of implementation of policies for the prevention of mother-to-child 
transmission of HIV, Malawi, South Africa and United Republic of Tanzania, 2013–2016
South Africa
The South Africa antiretroviral treatment guidelines. Pretoria: National Department of Health, South Africa; 2010.
Clinical guidelines: PMTCT (prevention mother to child transmission). Pretoria: National Department of Health and South African National AIDS Council, 
South Africa; 2010.
National HIV counselling and testing policy guidelines. Pretoria: National Department of Health, South Africa; 2010.
The South African antiretroviral treatment guidelines. Pretoria: National Department of Health, South Africa; 2013.
South African prevention of mother to child guidelines. Pretoria: National Department of Health, South Africa; 2015.
National HIV counselling and testing policy guidelines. Pretoria: National Department of Health, South Africa; 2015.
National consolidated guidelines for the prevention of mother to child transmission of HIV (PMTCT) and the management of HIV in children, adolescents 
and adults. Pretoria: National Department of Health, South Africa; 2015.
Guidelines for maternity care in South Africa, A manual for clinics, community health centres and district hospitals. Pretoria: National Department of 
Health, South Africa; 2015.
National HIV testing services policy. Pretoria: National Department of Health, South Africa; 2016.
Malawi
Guidelines for the use of ART in Malawi. 1st ed. Lilongwe: Ministry of Health, Malawi; 2003.
Prevention of mother to child transmission guidelines. Lilongwe: Ministry of Health, Malawi; 2004.
Guidelines for the use of ART in Malawi. 2nd ed. Lilongwe: Ministry of Health, Malawi; 2006.
Management of STIs, using syndromic management approach. 3rd ed. Lilongwe: Ministry of Health, Malawi; 2007.
Paediatric HIV testing and counselling. Lilongwe: Ministry of Health, Malawi; 2007.
Management of HIV associated diseases. 2nd edition. Lilongwe: Ministry of Health, Malawi; 2008.
Paediatric HIV testing and counselling. Lilongwe: Ministry of Health, Malawi; 2008.
Guidelines for the use of ART in Malawi. 3rd ed. Lilongwe: Malawi Ministry of Health; 2008.
HCT guidelines. Lilongwe: Ministry of Health, Malawi; 2009.
Prevention of mother to child transmission of HIV and paediatric HIV care guidelines. Lilongwe: Ministry of Health, Malawi; 2010.
Guidelines for the use of ART in Malawi. 3rd ed. Lilongwe: Malawi Ministry of Health; 2010.
Clinical management of HIV in children and adults: Malawi integrated guidelines. Lilongwe: Ministry of Health, Malawi; 2011.
National HIV and AIDS Strategic Plan 2011–2016. Lilongwe: Ministry of Health, Malawi; 2011.
Consolidated guidelines for the use of ART for treating and preventing HIV infection. Lilongwe: Ministry of Health, Malawi; 2013.
Malawi guidelines for clinical management of HIV in children and adults. Lilongwe: Ministry of Health, Malawi; 2014.
Viral load strategic scale up plan: increasing access to viral load testing in Malawi. Lilongwe: Ministry of Health, Malawi; 2015.
National strategic plan for HIV and AIDS: 2015–2020. Lilongwe: Ministry of Health, Malawi; 2015.
Consolidated guidelines on HIV testing services. Lilongwe: Ministry of Health, Malawi; 2015.
Consolidated strategic information guidelines. Lilongwe: Ministry of Health, Malawi; 2015.
National health information system policy. Lilongwe: Ministry of Health, Malawi; 2016.
Consolidated guidelines for the use of ART for treating and preventing HIV infection. Lilongwe: Ministry of Health, Malawi; 2016.
Consolidated guidelines for the prevention, diagnosis, treatment and care for key populations. Lilongwe: Ministry of Health, Malawi; 2016.
Guidelines on HIV self-testing and partner notification. Lilongwe: Ministry of Health, Malawi; 2016.
Guidelines for the clinical management of HIV. 3rd ed. Lilongwe: Ministry of Health, Malawi; 2016.
Guidelines on patient-centered HIV patient monitoring and case surveillance. Lilongwe: Ministry of Health, Malawi; 2017.
United Republic of Tanzania
National guidelines for the clinical management of HIV and AIDS. 2nd ed. Dar es Salaam: Tanzanian National AIDS Control Program; 2005.
Guidelines for HIV testing and counselling in clinical settings. Dar es Salaam: Tanzanian National AIDS Control Program; 2007.
National health policy. Dar es Salaam: Ministry of Health and Social Welfare, United Republic of Tanzania; 2007.
The national road map strategic plan to accelerate reduction of maternal, newborn and child deaths in United Republic of Tanzania. Dar es Salaam: 
Ministry of Health and Social Welfare, United Republic of Tanzania; 2008.
National guidelines for the clinical management of HIV and AIDS. 3rd ed. Dar es Salaam: Tanzanian National AIDS Control Program; 2009.
National guidelines for home based care services. Dar es Salaam: Tanzanian National AIDS Control Program; 2010.
National guidelines for the clinical management of HIV and AIDS. 4th ed. Dar es Salaam: Tanzanian National AIDS Control Program; 2012.
Antenatal care guidelines. Dar es Salaam: Ministry of Health and Social Welfare, United Republic of Tanzania; 2014.
National guidelines for comprehensive care of prevention of mother-to-child transmission of HIV. 3rd ed. Dar es Salaam: Ministry of Health and Social 
Welfare, United Republic of Tanzania; 2012.
National guidelines for comprehensive care services for prevention of mother-to-child transmission of HIV and keeping mothers alive. Dar es Salaam: 
Ministry of Health and Social Welfare, United Republic of Tanzania; 2013.
continues ...
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Supply stock-outs
The proportion of facilities reporting no 
stock-outs of HIV test kits in the year be-
fore the survey varied by round and site 
(Fig. 2). The Malawian and South Afri-
can sites had the highest proportion of 
facilities reporting no stock-outs across 
both rounds. In both Tanzanian sites, the 
proportion of facilities experiencing no 
stock-outs of HIV test kits in the past 
year was low, ranging from 0% to 30% 
in the two rounds. The median duration 
of the longest HIV test kit stock-outs 
in both South African sites was less 
than 2 weeks in both rounds (Fig. 3). 
In Karonga, the median duration of the 
longest stock-outs decreased from 105 
days to 28 days between round 1 and 2. 
In the United Republic of Tanzania, the 
median duration of the longest stock-
outs was 90 days and 75 days in Ifakara 
and Kisesa, respectively, in round 1, 
decreasing to between 30 days and 60 
days, respectively, by round 2.
A similar pattern was reported 
for maternal ARV drugs, with all sites 
having a higher proportion of facilities 
reporting no stock-outs by round 2 (or 
maintaining 100% of facilities reporting 
no stock-outs) except Ifakara. In Ifakara 
fewer facilities reported no maternal 
drug stock-outs by round 2; however, 
the median duration of the longest 
stock-out declined from 45 to 21 days 
over the two rounds.
In all sites, the proportion of fa-
cilities reporting no stock-outs of infant 
ARV drugs increased or remained at 
100% in all sites over the two rounds. 
The median duration of the longest 
stock-outs declined over the two rounds 
from 60 to 5 days in Ifakara and from 37 
to 7 days in Kisesa.
Discussion
Our study shows overall progress in 
delivering PMTCT services in five rural 
settings in Africa in line with WHO 
guidance, despite some implementa-
tion gaps and persistent supply-chain 
challenges. We found that in all study 
countries, national policies influencing 
the maternal and infant PMTCT cascade 
aligned with WHO guidelines by 2016, 
despite considerable variation in the 
year of adoption. Malawi was notable in 
having adopted several policies before 
their recommendation by WHO, includ-
ing same-day ART initiation and Option 
B+, and other countries have drawn les-
sons from Malawi’s experience.27 Over 
the study period, all sites improved the 
proportion of facilities that were imple-
menting policies designed to improve 
ART coverage among pregnant women. 
These policies include integration of 
ART services into antenatal care, same-
day initiation of ART and documenta-
tion of transfers from PMTCT into 
routine HIV care. These findings provide 
further evidence of progress achieved 
in these countries during the Global 
Plan years, contributing to ART cover-
age among pregnant women of 65%, 
90% and > 95% in Malawi, the United 
Republic of Tanzania and South Africa 
respectively.11
Our findings suggest that most 
of the variation across countries in 
the adoption and implementation of 
PMTCT policy concerned the delivery 
of HIV care within antenatal care ser-
vices, including the timing of the moth-
ers’ transfer to routine HIV care from 
antenatal clinics. Timings varied from 
42 days following delivery in Malawi 
and South Africa, to 2 years after deliv-
ery in the United Republic of Tanzania. 
This variation is likely explained by the 
broad guidance provided by WHO, and 
perhaps illustrates the lack of evidence 
on the relative merits of each strategy.28 
In particular, the extent to which these 
policy differences influence mothers’ 
retention in care is unclear, with high 
drop-out rates after transfer to routine 
care reported in some settings, regard-
less of the timing of the referral.8,29 
Further research should investigate the 
impact of service integration on PMTCT 
outcomes, and explore the perspectives 
of service providers and users on dif-
ferent models to inform future policy 
refinements.
Although infant testing, prophy-
laxis and treatment policies were well-
Third national multi-sectoral strategic framework for HIV and AIDS. Dar es Salaam: Prime Minister’s Office, United Republic of Tanzania; 2013.
Health sector strategic plan 2015–2020; HSSP IV: Reaching all households with quality health care. Dar es Salaam: Ministry of Health, United Republic 
of Tanzania; 2015.
National guidelines for the management of HIV and AIDS. Dar es Salaam: Ministry of Health, Community Development, Gender, Elderly and Children; 
United Republic of Tanzania; 2017.
World Health Organization
The right to know: new approaches to HIV testing and counselling. Geneva: World Health Organization; 2003.
Scaling-up HIV testing and counselling services: a toolkit for programme managers. Geneva: World Health Organization; 2003.
Patient monitoring guidelines for HIV care and ART. Geneva: World Health Organization; 2006.
Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Geneva: World Health Organization; 
2006.
Task shifting: global recommendations and guidelines. Geneva: World Health Organization; 2008.
Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva: World Health Organization; 2009.
Delivering HIV test results and messages for re-testing and counselling in adults. Geneva: World Health Organization; 2010.
Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: World Health Organization; 2010.
Program update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: World Health Organization; 2012.
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 
Geneva: World Health Organization; 2013.
AIDS: acquired immune deficiency syndrome; ART: antiretroviral therapy; HIV: human immunodeficiency virus.; HCT: HIV Counselling and Testing; HSSP: Health 
Sector Strategic Plan; STIs: Sexually Transmitted Infections.
... continued
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established in all three countries, imple-
mentation was not universal across the 
surveyed facilities, with variation within 
and between countries, and over survey 
rounds. Patchy implementation of these 
policies may be explained by insufficient 
capacity or resources, particularly in 
rural areas, and may help to explain 
why improvements in infant outcomes 
have lagged behind those in maternal 
outcomes in these countries.2 Our find-
ings align with other studies that suggest 
that greater focus is needed on service 
implementation across the infant cas-
cade of care if progress towards global 
targets for infants is to be accelerated.30
The introduction of Option B+ led 
to concerns that health systems may be 
insufficiently prepared for the resulting 
increase in client numbers. Our findings 
suggest that supplying sufficient HIV 
test kits to meet demand in these rural 
areas was a persistent challenge, with all 
sites still reporting stock-outs by round 
2. Stock-outs of HIV test kits may un-
dermine women’s confidence in the HIV 
services being offered,31 and may help 
to explain the persistently low uptake 
of HIV testing in some settings, includ-
ing the United Republic of Tanzania.32 
The overall reduction in maternal and 
infant ARV drug stock-outs between 
survey rounds, as well as in the median 
duration of the longest stock-out in the 
past 12 months, may indicate the suc-
cess of Option B+ in simplifying drug 
forecasting, procurement and stock 
monitoring.33 These findings also sug-
gest that concerns that Option B+ may 
over-burden health systems through 
increased client numbers have not been 
realized with regards to drug supply 
chains.34 Nevertheless, further evidence 
is needed to understand the impacts of 
Option B+ on other aspects of health 
systems including on the workforce 
and service delivery mechanisms such 
as integration.35
Our study has various limitations, 
including potential reporting bias given 
that survey responses were obtained 
from facility staff who may be inclined to 
overestimate some measures of service 
delivery. Reporting bias was minimized 
Table 2. Timing of publication of WHO recommendations on PMTCT of HIV and their adoption as policy by countries: maternal care, 
Malawi, South Africa and United Republic of Tanzania, 2013–2016 
WHO recommendation Study indicator Year 
guideline 
published 
Year guideline adopted as national policy
Malawi South Africa United Republic 
of Tanzania
HIV testing
Provider-initiated testing and counselling 
is standard for all clients, including in 
antenatal care
Provider-initiated 
testing and counselling 
implemented in antenatal 
care
2004 2006 2010 2007
Individual as well as group pre-test 













ART should be initiated in all pregnant 
and breastfeeding women living with 
HIV regardless of WHO clinical stage and 
at any CD4 cell count and be continued 
lifelong (Option B+)
Option B+ implemented 2013 2011 2015 2013
HIV treatment (for the mothers’ own 
health) should be given on same day as 
antenatal care services
HIV treatment given on 
same day as antenatal care 
services
2015 2011 2015 2013
In generalized epidemic settings, ART 
should be initiated and maintained at 
maternal and child health-care settings 
for eligible pregnant and postpartum 
women and for infants 
ART for pregnant women 
testing HIV-positive 
provided in the same 
building as antenatal care
2013 2011 2015 2012
Linkage to care
Clear guidance should be given on 
when HIV-positive pregnant women are 
referred to ART clinic
Women are referred to 
ART clinics from PMTCT 
during antenatal care or 
by 6 weeks post-delivery
2006 2011 2010 2013 
When child 
is 24 months 
old
Streamlined interventions should 
be done to reduce time between 
diagnosis and engagement in care, 
including (i) enhanced linkage with 
case management, (ii) support for HIV 
disclosure, (iii) patient tracing, (iv) training 
staff to provide multiple services and 
(v) streamlined services
Maternal referrals to 
HIV care and treatment 
services from PMTCT are 
documented
2013 Not explicit 2016 2009
Health worker 
accompanies woman 
during initial referral to 
routine ART services






Check if woman arrives in 
routine ART services
2004 Not explicit Not explicit 2010
ART: antiretroviral therapy; HIV: human immunodeficiency virus; PMTCT: prevention of mother-to-child transmission; WHO: World Health Organization.
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Table 4. Characteristics of facilities included in the study of implementation of PMTCT guidelines for HIV, Malawi, South Africa and 
United Republic of Tanzania, 2013–2016
Facility type No. (%) of health facilities
Malawi South Africa United Republic of Tanzania
Karonga (n = 5) Agincourt (n = 6) uMkhanyakudea (n = 17) Ifakara (n = 11) Kisesab (n = 7) 
Government-run 3 (60) 6 (100) 17 (100) 10 (91) 7b (100)
Faith-based 
organization-run
2 (40) 0 (0) 0 (0) 1 (< 1) 0 (0)
Dispensary 0 (0) 0 (0) 0 (0) 2 (18) 3 (43)
Small clinic 0 (0) 6 (100) 17 (100) 0 (0) 0 (0)
Large clinic or small 
health centre
0 (0) 0 (0) 0 (0) 3 (27) 0 (0)
Large health centre 
or small sub-district 
hospital
5 (100) 0 (0) 0 (0) 4 (36) 1 (14)
District hospital or 
large hospital
0 (0) 0 (0) 0 (0) 1 (9) 1 (14)
Referral hospital 0 (0) 0 (0) 0 (0) 1 (9) 2 (29)
HIV: human immunodeficiency virus.
a  In uMkhanyakude 10 facilities were outside that system and in Kisesa 3 facilities were outside the health and demographic surveillance system.
b  In Kisesa 1 of the 7 facilities were government-run, but managed by a faith-based organization.
Note: n is the total number of facilities offering antenatal care and prevention of mother-to-child transmission services participating in health and demographic 
surveillance system surveys at that site.
Table 3. Timing of publication of WHO recommendations on PMTCT of HIV and their adoption as policy by countries: infant care, Malawi, 
South Africa and United Republic of Tanzania, 2013–2016
WHO recommendation Study indicator Year 
guideline 
published




United Republic of 
Tanzania
Testing
All HIV-exposed infants have HIV virological testing 
at 4–6 weeks of age or at the earliest opportunity 
thereafter
Early infant diagnosis 
offered by 6 weeks or 
as early as possible 
thereafter
2010 2007 2004 2012
Infant prophylaxis
Infants of mothers who are receiving ART and are 
breastfeeding should receive 6 weeks of infant 
prophylaxis with daily nevirapine. If infants are 
receiving replacement feeding, they should be 
given 4–6 weeks of infant prophylaxis with daily 
nevirapine (or twice-daily zidovudine). Infant 
prophylaxis should begin at birth or when HIV 
exposure is recognized postpartum
Infant prophylaxis 
provided for 4–6 weeks 
postpartum
2010 2011 2015 2012
Infant prophylaxis 
provided until cessation 
of breastfeeding
2009 2011 2010 2012
National authorities should decide whether health 
services will principally counsel mothers to either 
exclusively breastfeed and receive ART interventions 
or avoid all breastfeeding, as the strategy that will 
most likely give infants the greatest chance of HIV-
free survival. Where breastfeeding is judged to be 
the best option: exclusively breastfeed for the first 
6 months, introduce appropriate complementary 
food thereafter, and continue breastfeeding for 
12 months; wean gradually within 1 month
Counselling on infant 
feeding provided
2010 2016 2015 2012
Infant care
Not addressed Infant and paediatric 
ART provided in all 
facilities which offer 
ART for adults
NA 2011 2015 2005
ART: antiretroviral therapy; HIV: human immunodeficiency virus; NA: not applicable; WHO: World Health Organization.
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for some indicators by triangulating 
responses with observations in the 
facilities, including for availability of 
treatment guidelines. We also consulted 
pharmacy records to validate reports of 
drug stocks and test availability. Our 
data cover the period from 2013 to 2016, 
and the accelerated roll-out of universal 
Test and Treat28 since 2016 may have led 
to changes in implementation of Option 
B+ policies. Furthermore, the timing of 
survey rounds differed between coun-
tries, making it difficult to compare the 
findings across settings. We selected 
facilities because they served the health 
and demographic surveillance system 
site populations; therefore, facilities 
were not nationally representative and 
this limits the generalizability of our 
findings. However, the facilities can be 
considered typical of those found in ru-
ral areas in each country. Using a similar 
analytical approach, data from national-
Table 6. Facility-level provision of infant care in the study of implementation of PMTCT guidelines for HIV in rural Malawi, South Africa 
and United Republic of Tanzania, 2013–2016
Infant care indicator No. (%) of health facilities
Malawi South Africa United Republic of Tanzania
Karonga (n = 5) Agincourt (n = 6) uMkhanyakude 
(n = 17)
Ifakara (n = 11) Kisesa (n = 7)




by 6 weeks or as 
early as possible 
thereafter
5 (100) 4 (80) 6 (100) 6 (100) 17 (100) 17 (100) 11 (100) 10 (91) 5 (70) 7 (100)
Infant prophylaxis
Infant prophylaxis 
provided 4–6 weeks 
postpartum or 
until cessation of 
breastfeeding









2 (40) 4 (80) 6 (100) 6 (100) 16 (94) 17 (100) 11 (100) 9 (82) 7 (100) 7 (100)
Routine care
Infant and paediatric 
ART provided in all 
facilities which offer 
ART for adults
5 (100) 4 (80) 6 (100) 6 (100) 17 (100) 17 (100) 9 (82) 10 (90) 4 (57) 3 (43)
ART: antiretroviral therapy; HIV: human immunodeficiency virus.
Note: n is the total number of facilities offering antenatal care and prevention of mother-to-child transmission services participating in health and demographic 
surveillance system surveys at that site.
Fig. 1. Location of ART provision during antenatal care in the study of implementation 




















In the same room as 
antenatal care
Same building as 
antenatal care
Same facility but 
different building to 
antenatal care
In another facility
Location of ART Provision
Round 1 Round 2
ART: antiretroviral therapy; HIV: human immunodeficiency virus.
Note: Total number of facilities: Karonga (n = 5); Agincourt (n = 6); uMkhanyakude (n = 17); Ifakara, (n = 11); Kisesa (n = 7).
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ly representative health-facility surveys 
(e.g. those using service availability and 
readiness assessment methods) could 
be used for future assessments of HIV 
policy implementation. Finally, further 
investigations are needed to understand 
why gaps occur and how these may be 
addressed, as well as to assess the pro-
portion of clients that receive care in line 
with national guidelines and the impact 
of policy implementation on patient 
outcomes, including retention in care, 
mortality or ART coverage.
In conclusion, we found general 
alignment of national PMTCT policies 
with WHO guidance, and substantial 
progress in their facility-level imple-
mentation in five rural African settings 
between 2013 and 2016. However, gaps 
in implementation of infant care policies 
persisted in all sites, threatening to un-
dermine efforts to eliminate new infant 
HIV infections by 2020. Concerns that 
supply chains could not cope with ad-
ditional client numbers from PMTCT 
policy changes have not been met, al-
though occurrences of stock-outs may 
undermine progress if the causes are 
not addressed. ■
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Fig. 2. Proportion of health facilities with no stock-outs in the past year for HIV test kits and maternal and infant antiretroviral drugs 




























HIV tests kits Maternal ARV Infant ARV
Round 2 higher Round 2 lower Round 1 = Round 2
Karonga 
Malawi
Agincourt uMkhanyakude Ifakara Kisesa 




Agincourt uMkhanyakude Ifakara Kisesa 




Agincourt uMkhanyakude Ifakara Kisesa 
South Africa United Republic 
of  Tanzania
ARV: antiretroviral drugs; HIV: human immunodeficiency virus.
Note: Total number of facilities: Karonga (n = 5); Agincourt (n = 6); uMkhanyakude (n = 17); Ifakara, (n = 11); Kisesa (n = 7).
Fig. 3. Median length of the longest stock-out in the past year for HIV test kits and 
maternal and infant antiretroviral drugs in the study of implementation of 
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United Republic of Tanzania
Ifakara
Kisesa
ARV: antiretroviral drugs; HIV: human immunodeficiency virus.
Note: Data were missing from Kisesa in round 2 and Agincourt in round 1.
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摘要
马拉维、南非和坦桑尼亚联合共和国于 2013-2016 年对农村地区实施艾滋病毒母婴传播预防政策
目的 旨在评估将世界卫生组织 (WHO) 的指导方针纳





儿护理联动提供的 15 项指标。在 2013 年至 2015 年



















Mise en œuvre des politiques de prévention de la transmission du VIH de la mère à l'enfant dans des zones rurales d'Afrique du 
Sud, du Malawi et de République-Unie de Tanzanie, 2013–2016
Objectif Évaluer la transposition des recommandations de l'Organisation 
mondiale de la Santé (OMS) dans les politiques nationales de prévention 
de la transmission mère-enfant (PTME) du virus de l'immunodéficience 
humaine (VIH) et contrôler l'application de ces politiques dans les 
centres de santé de zones rurales d'Afrique du Sud, du Malawi et de 
République-Unie de Tanzanie.
Méthodes Nous avons répertorié les politiques nationales de PTME et 
les recommandations de l'OMS pour 15 indicateurs, sur toute la chaîne 
de soins de santé de la mère et du nourrisson, sur la période comprise 
entre 2013 et 2016. Deux séries d'enquêtes ont été réalisées (2013-2015 
et 2015-2016) dans 46 centres de santé au service des populations de 
cinq systèmes de surveillance démographique et de santé. Nous avons 
interrogé les responsables de ces centres à l'aide de questionnaires 
directifs afin d'obtenir une description de la prestation des soins. Nous 
avons calculé la proportion de centres ayant appliqué chaque indicateur 
ainsi que la fréquence et la durée des ruptures de stock de fournitures, 
pour chaque zone étudiée et chaque série d'enquêtes.
Résultats En 2016, dans tous les pays étudiés, les lignes directrices 
de l'OMS avaient été prises en compte dans les politiques nationales 
relatives à la chaîne des soins de PTME du VIH; la plupart des différences 
constatées entre les politiques de ces différents pays concernaient la 
liaison avec les soins de routine contre le VIH. La proportion des centres 
offrant des conseils après dépistage, proposant de débuter une thérapie 
antirétrovirale (TAR) le jour même, fournissant dans un même endroit 
des soins prénataux et des TAR et appliquant l'Option B+ a augmenté 
ou est restée à 100% dans toutes les zones étudiées. Les progrès dans 
صخلم
 بونج في ةيفيرلا قطانلما في لفطلا لىإ ملأا نم )HIV( ةيشربلا ةعانلما صقن سويرف لاقتنا نم ةياقولا تاسايس ذيفنت
2016-2013 ،يولامو ةدحتلما اينازنت ةيروهجمو ايقيرفأ
 في  (WHO)  ةيلماعلا  ةحصلا  ةمظنم  دماتعا  مييقت  ضرغلا
 لفطلا  لىإ ملأا نم ىودعلا  لاقتنا  نم ةياقولل ةينطولا  تاسايسلا
 ةبقارمو  (HIV)  ةيشربلا  ةعانلما  صقن  سويرفل  (PMTCT)
 في  ةيفيرلا  قطانلما  في  قفارلما  ىوتسم  لىع  ةيهيجوتلا  ئدابلما  ذيفنت
.يولامو ةدحتلما اينازنت ةيروهجمو ايقيرفأ بونج
 لاقتنا  نم  ةياقولل  ةينطولا  تاسايسلا  صيخلتب  انمق  دقل  ةقيرطلا
 ةمظنم  تاهيجوتو  (PMTCT)  لفطلا  لىإ  ملأا  نم  ىودعلا
 ةياعر  ةزهجأ  ةلسلس  برع  شرؤم  15  لجأ  نم  ةيلماعلا  ةحصلا
 تيرجُأ  .2016و  2013  ينب  ام  ةترفلا  للاخ  ةلوفطلاو  ةموملأا
 ًاقفرم  46  في  (2016-2015و  2015-2013)  حسم  اتلوج
 انمق .ةيفارغوميدو ةيحص ةبقارم ماظن تاعمتمج ةسخم مديخ ًايحص
 .ةمدلخا  ميدقت  فصول  قفارلما  يريدلم  ةمظنم  تانايبتسا  ةرادإب
 راركتو  شرؤم  لكل  ةقبطلما  تلايهستلا  بسن  نع  غلابلإاب  انمقو
.حسلما ةلوجو عقولما بسح مزاوللا نوزمخ ددمو
 لىع رثؤت يتلا ةينطولا تاسايسلا تمتها ،نادلبلا عيجم في جئاتنلا
 نم ىودعلا  لاقتنا  نم ةياقولل  عضرلاو تاهملأل ةياعرلا  ةلسلس
 ةيهيجوتلا  ئدابلما  عم  ةقفاوتلماو  (PMTCT)  لفطلا  لىإ  ملأا
 في  تايرغتلا  مظعمو  ؛2016  ماع  لولحب  ةيلماعلا  ةحصلا  ةمظنلم
 سويرفل ةينيتورلا ةياعرلاب طابترلااب اًضيأ نادلبلا ينب تاسايسلا
 مدقت  يتلا  قفارلما  ةبسن  تعفتراو  .(HIV)  ةيشربلا  ةعانلما  صقن
 تاسويرفلا  تاداضمب  جلاعلا  في  ءدبلاو  ،رابتخلاا  دعب  ةروشلما
 يرفوتو ،ةدلاولل ةقباسلا ةياعرلاو ،مويلا سفن في (ART) ةيعجرلا
 رايلخاو  ،ىنبلما  سفن  في  ةيعجرلا  تاسويرفلا  تاداضمب  جلاعلا
 توافت دقو .عقاولما عيجم في 100٪ ةبسنب ىقب وأ داز يذلا + ب
 ينب مهجلاعو عضرلا صيخشتب ةقلعتلما تاسايسلا ذيفنت في مدقتلا
 ةعانلما صقن سويرف رابتخا تاعوممج نوزمخ ضفخنا ماك .عقاولما
 ماعلا في ةيعجرلا تاسويرفلل ةداضلما يرقاقعلا وأ (HIV) ةيشربلا
 دحاو قفرم لبق نم كلذ نع غلابلإا مت نكلو ،ماع لكشب ضيالما
.ينتلولجا اتلك في عقوم لكل لقلأا لىع
 ىودعلا لاقتنا نم ةياقولا ةسايس ذيفنت في مدقت زارحإ مت جاتنتسلاا
 نإف ،كلذ عمو .فورظلا هذه في (PMTCT) لفطلا لىإ ملأا نم
 ةلسلس  تايّدتحو  عضرلا  ةياعر  ةلسلس  برع  ةرمتسلما  تارغثلا
 ةيشربلا  ةعانلما  صقن سويرف لىع ءاضقلا  فادهأ ضّوقت ديروتلا
.عضرلا ىدل
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l'application des politiques en matière de diagnostic et de traitement 
du nourrisson ont été variables d'une zone à une autre. Les ruptures de 
stock de kits de dépistage du VIH ou de médicaments antirétroviraux 
au cours de l'année précédente ont généralement diminué, mais dans 
chaque zone, sur les deux périodes étudiées, au moins une structure a 
été confrontée à ce problème.
Conclusion Des progrès ont été faits dans l'application des politiques 
de PTME dans ces régions. Néanmoins, des manquements persistants 
dans la chaîne de soins de santé du nourrisson et les problèmes des 
chaînes d'approvisionnement risquent de compromettre l'atteinte des 
objectifs d'élimination du VIH chez le nourrisson.
Резюме
Внедрение стратегий профилактики передачи ВИЧ от матери ребенку в сельских районах Малави, 
Объединенной Республики Танзания и Южной Африки в 2013–2016 гг.
Цель Оценка включения рекомендаций Всемирной организации 
здравоохранения (ВОЗ) в национальные стратегии профилактики 
передачи вируса иммунодефицита человека (ВИЧ) от матери 
ребенку (РМТСТ) и отслеживание внедрения таких рекомендаций 
на уровне объектов здравоохранения в сельских районах 
Малави, Объединенной Республики Танзания и Южной Африки.
Методы Авторы суммировали национальные стратегии в 
отношении PMTCT и рекомендации ВОЗ по 15 индикаторам в 
цепочке мероприятий по оказанию помощи матери и ребенку 
на протяжении 2013–2016 гг. Исследование проводилось в 
виде двух раундов опросов (2013–2015 гг. и 2015–2016 гг.) в 
46 учреждениях здравоохранения, которые обслуживали пять 
популяций систем надзора за здоровьем и демографической 
ситуацией. Руководителям учреждения здравоохранения были 
выданы структурированные анкеты для описания оказания услуг. 
В статье приведены сведения о доле учреждений, внедривших 
каждый из индикаторов, а также о частоте и продолжительности 
случаев нехватки ресурсов с разбивкой по зонам оказания услуг 
и раунду опросов.
Результаты Во всех странах национальные стратегии, влияющие 
на цепочку предоставления услуг в отношении материнского и 
детского РМТСТ, были приведены в соответствие с рекомендациями 
ВОЗ к 2016 г. Большинство вариантов стратегий в разных странах 
касались привязки к плановому лечению ВИЧ-инфицированных. 
Доля медицинских учреждений, предоставляющих возможность 
консультации после тестирования, начала антиретровирусной 
терапии (АРТ) в тот же день, дородового лечения и АРТ в том 
же здании, а также предоставляющих вариант В+, выросла или 
осталась на уровне 100% во всех обследованных зонах. Прогресс 
во внедрении стратегий диагностики и лечения младенцев 
различался в зависимости от зоны исследования. Дефицит тест-
систем для выявления антител к ВИЧ или антиретровирусных 
препаратов за последний год в целом уменьшился, но сообщения 
о нехватке поступали по меньшей мере из одного учреждения в 
каждой зоне в течение обоих опросов.
Вывод Наблюдается прогресс во внедрении стратегий PMTCT 
в указанных условиях. Однако постоянные недочеты в цепочке 
предоставления услуг младенцам и проблемы с поставками могут 
поставить под угрозу цели по устранению ВИЧ у младенцев.
Resumen
Aplicación de políticas de prevención de la transmisión del VIH de madre a hijo en las zonas rurales de Malawi, la República 
Unida de Tanzanía y Sudáfrica, 2013-2016
Objetivo Evaluar la adopción de las directrices de la Organización 
Mundial de la Salud (OMS) en las políticas nacionales de prevención 
de la transmisión del virus de la inmunodeficiencia humana (VIH) de 
madre a hijo y supervisar la aplicación de las directrices a nivel de las 
instalaciones sanitarias en las zonas rurales de Malawi, la República 
Unida de Tanzanía y Sudáfrica.
Métodos Resumimos las políticas nacionales de PTMI y las directrices 
de la OMS para 15 indicadores en toda la serie de servicios de atención 
maternoinfantil durante el período 2013-2016. Se realizaron dos rondas 
de encuestas (2013-2015 y 2015-2016) en 46 instalaciones sanitarias 
que atienden a cinco poblaciones del sistema de vigilancia sanitaria y 
demográfica. Se administraron cuestionarios estructurados a los gestores 
de las instalaciones para describir la prestación de servicios. Informamos 
las proporciones de las instalaciones que aplican cada indicador y la 
frecuencia y duración de la falta de existencias de suministros, por 
emplazamiento y ronda de encuestas.
Resultados En todos los países, las políticas nacionales que influyen en 
la serie de servicios de atención maternoinfantil de la PTMI se ajustaron 
a las directrices de la OMS para 2016; la mayoría de las variaciones de 
las políticas entre países se referían a la vinculación con la atención 
habitual de la infección por el VIH. La proporción de instalaciones que 
ofrecen asesoramiento posterior a la prueba, iniciación de la terapia 
antirretrovírica en el mismo día, atención prenatal y suministro de terapia 
antirretrovírica en el mismo edificio, y la Opción B+ aumentaron o se 
mantuvieron en el 100 % en todos los emplazamientos. El progreso en 
la aplicación de las políticas de diagnóstico y tratamiento del lactante 
varió de un emplazamiento a otro. Las existencias de kits de pruebas 
del VIH o de medicamentos antirretrovirales se redujeron en general en 
el último año, pero en ambas rondas se informó de la existencia de al 
menos una instalación por emplazamiento.
Conclusión Se ha progresado en la aplicación de la política de PTMI 
en estos ámbitos. Sin embargo, las persistentes brechas en la serie de 
servicios de atención infantil y los desafíos de la cadena de suministro 
pueden socavar los objetivos de eliminación del VIH infantil.
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